Terms: = Pancreatic cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Prognosis
13 results:
1. The Diagnostic and Prognostic Value of miR-155 in cancers: An Updated Meta-analysis.
Wu Y; Hong Q; Lu F; Zhang Z; Li J; Nie Z; He B
Mol Diagn Ther; 2023 May; 27(3):283-301. PubMed ID: 36939982
[TBL] [Abstract] [Full Text] [Related]
2. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
[TBL] [Abstract] [Full Text] [Related]
3. A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma.
Xu K; Xia P; Liu P; Zhang X
Sci Rep; 2022 Dec; 12(1):20781. PubMed ID: 36456877
[TBL] [Abstract] [Full Text] [Related]
4. The relationships between antihypertensive medications and the overall survival of patients with pancreatic cancer: a systematic review and meta-analysis.
Jiang W; He R; Lu Y; Zhou W
Expert Rev Gastroenterol Hepatol; 2022 Jun; 16(6):547-553. PubMed ID: 35686669
[TBL] [Abstract] [Full Text] [Related]
5. Analyzing and predicting the LNM rate and prognosis of patients with intraductal papillary mucinous neoplasm of the pancreas.
Tang CT; Liu BX; Chen Y; Zeng C
Cancer Med; 2021 Mar; 10(6):1925-1935. PubMed ID: 33641255
[TBL] [Abstract] [Full Text] [Related]
6. cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy.
Zhang YP; Bao ZW; Wu JB; Chen YH; Chen JR; Xie HY; Zhou L; Wu J; Zheng SS
Technol Cancer Res Treat; 2020; 19():1533033820944274. PubMed ID: 32715976
[TBL] [Abstract] [Full Text] [Related]
7. Validation of the American Joint Committee on cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
Shin DW; Lee JC; Kim J; Woo SM; Lee WJ; Han SS; Park SJ; Choi KS; Cha HS; Yoon YS; Han HS; Hong EK; Hwang JH
Eur J Surg Oncol; 2019 Nov; 45(11):2159-2165. PubMed ID: 31202572
[TBL] [Abstract] [Full Text] [Related]
8. Waiting time to surgery and pancreatic cancer survival: A nationwide population-based cohort study.
Kirkegård J; Mortensen FV; Hansen CP; Mortensen MB; Sall M; Fristrup C
Eur J Surg Oncol; 2019 Oct; 45(10):1901-1905. PubMed ID: 31160135
[TBL] [Abstract] [Full Text] [Related]
9. Meta-analysis on resected pancreatic cancer: a comparison between adjuvant treatments and gemcitabine alone.
Chen H; He R; Shi X; Zhou M; Zhao C; Zhang H; Qin R
BMC Cancer; 2018 Oct; 18(1):1034. PubMed ID: 30352573
[TBL] [Abstract] [Full Text] [Related]
10. Impact of histologically confirmed lymph node metastases on patient survival after surgical resection for hepatocellular carcinoma: report of a Japanese nationwide survey.
Hasegawa K; Makuuchi M; Kokudo N; Izumi N; Ichida T; Kudo M; Ku Y; Sakamoto M; Nakashima O; Matsui O; Matsuyama Y;
Ann Surg; 2014 Jan; 259(1):166-70. PubMed ID: 23532111
[TBL] [Abstract] [Full Text] [Related]
11. Spindle proteins in resected pancreatic head adenocarcinomas: bubr1 is an independent prognostic factor in pancreatobiliary-type tumours.
Gladhaug IP; Westgaard A; Schjølberg AR; Burum-Auensen E; Pomianowska E; Clausen OP
Histopathology; 2010 Feb; 56(3):345-55. PubMed ID: 20459534
[TBL] [Abstract] [Full Text] [Related]
12. The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma.
Miknyoczki SJ; Chang H; Klein-Szanto A; Dionne CA; Ruggeri BA
Clin Cancer Res; 1999 Aug; 5(8):2205-12. PubMed ID: 10473107
[TBL] [Abstract] [Full Text] [Related]
13. The novel Trk receptor tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits antitumor efficacy against human pancreatic carcinoma (Panc1) xenograft growth and in vivo invasiveness.
Miknyoczki SJ; Dionne CA; Klein-Szanto AJ; Ruggeri BA
Ann N Y Acad Sci; 1999 Jun; 880():252-62. PubMed ID: 10415871
[TBL] [Abstract] [Full Text] [Related]
